Font Size: a A A
Keyword [Molecular targeted]
Result: 21 - 40 | Page: 2 of 7
21. Design And Synthesis Study Of 2-indolinone Derivatives As Inhibitors Of Receptor Tyrosine Kinase And The Screening Of Compoud-activities
22. Expression Characteristics Of Molecular-Targeted HIF-1α And Its Association With Occurrence And Development Of The Malignant Transformation Of Hepatocytes
23. Expression Characteristics Of Molecular-targeted Hif-1α And Its Association With Occurrence And Development Of The Malignant Transformation Of Hepatocytes
24. Molecular Targeted Therapy For Breast Cancer Chemotherapy Sensitizing Effect
25. Experimental Study On The Expression And Function Of PC4in Non-small Cell Lung Cancer
26. Peptide-lipid Nanoprobes For The Theranostics Of Nasopharyngeal Carcinoma
27. Clinical Curative Effect Review Of Molecular Targeted Drug Sorafenib In Primary Liver Cancer
28. Anti-tumor Efficacy And Molecular Mechanism Study Of Novel Prodrug Of DOX In Treatment Of Gastric Cancer
29. Research On Molecular Targeted Therapy Of Gastric Cancer Based On PDTX Models
30. The Experimental Study Of Preparation Of Nanoscale Molecular Targeted Ultrasound Contrast Agents And Tumor Targeted Imaging
31. Antitumor Effects Of The Dual MTORC1/2 Inhibitor AZD2014 In Hepatocellular Carcinoma And Its Antirejection Effects In Rat Liver Transplantation
32. Study Of The Inhibitory Effects Of β-hydroxyisovalerylshikonin On The Cervical Cancer Via PI3K/AKT/mTOR Signaling Pathway
33. Study On Mechanism Of Polo-like Kinase 2 Prohibiting TAp73 Function Against Osteosarcoma
34. Combination Treatment Of Transarterial Chemoembolization Plus Molecular Targeted Agents In Patients With Unresectable Hepatocellular Carcinoma:Efficacy And Prognostic Assessments
35. Clinical Analysis For Small Intestinal Stromal Tumor:Review Of74Cases
36. The Clinical Observation Of Sorafenib In78Patients With Advanced Renal Cell Carcinoma
37. Advances In Diagnosis And Treatment Of Uterine Papillary Serous Carcinoma
38. Design And Synthesis Of Multi-aromatic Deri Vatives As HGF/c-met Protein Tyrosine Kinase Inhibitors
39. A Analysis Observation Of Concomitant Therapy Of Molecular Targeted Therapy And Whole Brain Radiotherapy In Patients Of NSCLC Combined With Brain Metastases
40. The Effect And Mechanism Of Blocking EGFR And MTOR Signaling Pathway In Nasopharyngeal Carcinoma Resistant To EGFR-TKI
  <<First  <Prev  Next>  Last>>  Jump to